Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLUTO trial of Plasma-Lyte 148 versus standard intravenous fluids in paediatric kidney transplantation
2019-003025-22Phase 4Unknown
- Sponsor
- Great Ormond Street Hospital
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of plasma-lyte in end-stage kidney disease (ESKD) and Kidney allograft status (RTx) (2 arms), sponsored by Great Ormond Street Hospital. Primary endpoint: Acute hyponatraemia in the first 72 hours post-transplant. Status: unknown.
02
Drugs
plasma-lyte
03
Conditions
end-stage kidney disease (ESKD)Kidney allograft status (RTx)
Beyond the preview
Go deeper on 2019-003025-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003025-22.